RPR Liquid Controls are in vitro diagnostic reagents used to monitor the performance of RPR card tests. The controls consist of positive and negative samples used by laboratory personnel to verify the accuracy and reliability of the RPR assay procedure. By comparing the results obtained with the REMEL controls against expected outcomes, clinicians ensure the test system is functioning correctly before reporting patient results. This quality assurance process helps maintain the integrity of diagnostic testing for syphilis, ensuring that patient results are accurate and reliable.
Clinical Evidence
Bench testing only. Comparative performance data collected at multiple clinical sites (Mich. Dept. PH, UTex) over several months. REMEL positive and negative controls were tested alongside reference controls (Difco). Results showed consistent agreement in qualitative reactivity (Reactive/Non-Reactive) and reactivity strength (e.g., 4+/mR) across all dates and sites.
Technological Characteristics
In vitro diagnostic liquid reagents. Formulated as positive and negative controls for RPR card agglutination assays. Standalone reagents; no electronic or software components.
Indications for Use
Indicated for use as quality control reagents for RPR (Rapid Plasma Reagin) card tests to monitor the performance of the assay.
Regulatory Classification
Identification
Treponema pallidum nontreponemal test reagents are devices that consist of antigens derived from nontreponemal sources (sources not directly associated with treponemal organisms) and control sera (standardized sera with which test results are compared) used in serological tests to identify reagin, an antibody-like agent, which is produced from the reaction of treponema microorganisms with body tissues. The identification aids in the diagnosis of syphilis caused by microorganisms belonging to the genus Treponema and provides epidemiological information on syphilis.
Reference Devices
Difco RPR Card Test Controls
Related Devices
K980638 — ADI SYPHILIS RPR LIQUID CONTROLS · Ampcor Diagnostics, Inc. · Jul 6, 1998